TWA
TCI Wealth Advisors’s Sangamo Therapeutics SGMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,707
| Closed | -$3.01K | – | 1893 |
|
|
2023
Q1 | $3.01K | Buy |
1,707
+1,207
| +241% | +$2.13K | ﹤0.01% | 1850 |
|
|
2022
Q4 | $1.57K | Sell |
500
-828
| -62% | -$2.6K | ﹤0.01% | 2025 |
|
|
2022
Q3 | $7K | Hold |
1,328
| – | – | ﹤0.01% | 1288 |
|
|
2022
Q2 | $5K | Buy |
1,328
+828
| +166% | +$3.12K | ﹤0.01% | 1531 |
|
|
2022
Q1 | $3K | Buy |
500
+100
| +25% | +$600 | ﹤0.01% | 1917 |
|
|
2021
Q4 | $3K | Sell |
400
-200
| -33% | -$1.5K | ﹤0.01% | 2034 |
|
|
2021
Q3 | $5K | Sell |
600
-382
| -39% | -$3.18K | ﹤0.01% | 1630 |
|
|
2021
Q2 | $12K | Sell |
982
-484
| -33% | -$5.91K | ﹤0.01% | 852 |
|
|
2021
Q1 | $18K | Buy |
1,466
+166
| +13% | +$2.04K | 0.01% | 595 |
|
|
2020
Q4 | $20K | Sell |
1,300
-1,400
| -52% | -$21.5K | 0.01% | 476 |
|
|
2020
Q3 | $26K | Sell |
2,700
-100
| -4% | -$963 | 0.01% | 387 |
|
|
2020
Q2 | $25K | Hold |
2,800
| – | – | 0.01% | 393 |
|
|
2020
Q1 | $18K | Buy |
2,800
+200
| +8% | +$1.29K | 0.01% | 456 |
|
|
2019
Q4 | $22K | Sell |
2,600
-1,200
| -32% | -$10.2K | 0.01% | 527 |
|
|
2019
Q3 | $34K | Buy |
3,800
+200
| +6% | +$1.79K | 0.02% | 391 |
|
|
2019
Q2 | $39K | Buy |
3,600
+100
| +3% | +$1.08K | 0.02% | 355 |
|
|
2019
Q1 | $33K | Buy |
3,500
+100
| +3% | +$943 | 0.01% | 412 |
|
|
2018
Q4 | $39K | Buy |
3,400
+800
| +31% | +$9.18K | 0.02% | 346 |
|
|
2018
Q3 | $44K | Buy |
2,600
+700
| +37% | +$11.8K | 0.02% | 356 |
|
|
2018
Q2 | $27K | Buy |
1,900
+700
| +58% | +$9.95K | 0.01% | 428 |
|
|
2018
Q1 | $23K | Buy |
1,200
+700
| +140% | +$13.4K | 0.01% | 456 |
|
|
2017
Q4 | $8K | Buy |
+500
| New | +$8K | ﹤0.01% | 685 |
|